Our Blog

12 Oct

Mesoblast join with Tasly for China deal

By Finance News

12 Oct 2018 – Regenerative medicine comapny Mesoblast (ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic partnership in China for Mesoblast’s product candidates for heart failure.


Source: Finance News Network

Share this post

Related Posts

14 Dec

Orocobre signs agreements with Toyota Tsusho Corporation

14 Dec 2018 - Lithium producer Orocobre (ASX:ORE) has signed three pivotal agreements with... read more

30 May

BluGlass (ASX:BLG) Placement and SPP to expand capacity

30 May 2018 - BluGlass (ASX:BLG) Managing Director, Giles Bourne talks about expansion plans... read more

05 Sep

Senex to acquire Planet Gas Cooper Basin assets

05 Sep 2018 - Senex (ASX:SXY) has entered into an agreement with Planet Gas... read more

05 Jan

ASX catches US tailwind: Aus shares 0.56% higher at noon

05 Jan 2018 - ASX catches US tailwind: Aus shares 0.56% higher at noon.... read more

06 Mar

Capral’s FY17 earnings impacted by rising aluminum billet price

06 Mar 2018 - Aluminium manufacturing company Capral Aluminium (ASX:CAA) has announced its profit... read more

10 Dec

TPG joint venture acquires 5G spectrum nationally

10 Dec 2018 - TPG Telecom (ASX:TPM) and joint venture partner, Mobile JV have... read more

16 Aug

Energy fuels the charge: Aus shares close 0.48% higher

18 Aug 2017 - Energy fuels the charge: Aus shares close 0.48% higher. National... read more

02 Nov

Credit Corp Group acquires Thorn Group’s Cashfirst loan book

02 Nov 2017 - Credit Corp Group (ASX:CCP) acquires Thorn Group’s (ASX:TGA) Cashfirst branded... read more

01 Jun

Pengana buys stake in Global Credit Investments

01 Jun 2018 - Pengana Capital Group (ASX:PCG) has bought a strategic minority stake... read more

29 Oct

Kogan posts 1QFY19 fall in revenue

29 Oct 2018 - Kogan (ASX:KGN) has today announced first quarter 2019 global brands... read more